BlossomHill Therapeutics, Inc. (BLSM)

BlossomHill Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BlossomHill Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	-	7.89	4.59
Research & Development	-	56.14	31.81
Operating Expenses	-	64.02	36.4
Operating Income	-74.68	-64.02	-36.4
Interest Expense (Income)	-3.61	-3.48	-5.71
Other Expense (Income)	0.01	0.01	-
Pretax Income	-71.09	-60.56	-30.7
Net Income	-71.09	-60.56	-30.7
Free Cash Flow	-57.56	-47.99	-31.51
EBITDA	-74.21	-63.59	-36.05
Depreciation & Amortization	0.48	0.44	0.35
EBIT	-74.69	-64.04	-36.4